analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.
Company profile
Ticker
A
Exchange
Website
CEO
Michael McMullen
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
AGILENT TECHNOLOGIES INC
SEC CIK
Corporate docs
Subsidiaries
Agilent Technologies Luxco LLC • Agilent Technologies Singapore (Global) Pte Ltd. • Agilent Technologies Singapore (Holding) Pte. Ltd. • Agilent Technologies Singapore (International) Pte. Ltd. • Agilent Technologies World Trade, Inc. • Dako Denmark ApS ...
IRS number
770518772
A stock data
Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
15 Mar 24
10-Q
2024 Q1
Quarterly report
4 Mar 24
8-K
Agilent Reports First-Quarter Fiscal Year 2024 Financial Results
27 Feb 24
8-K
CrossLab Group President Padraig McDonnell Named CEO-Elect
21 Feb 24
DEF 14A
Definitive proxy
2 Feb 24
ARS
2023 FY
Annual report to shareholders
2 Feb 24
8-K
Regulation FD Disclosure
5 Jan 24
8-K
Agilent Makes Strategic Updates to Organizational Structure
20 Dec 23
10-K
2023 FY
Annual report
19 Dec 23
8-K
Agilent Reports Fourth-Quarter Fiscal Year 2023 Financial Results
20 Nov 23
Transcripts
A
Earnings call transcript
2024 Q1
27 Feb 24
A
Earnings call transcript
2023 Q4
20 Nov 23
A
Earnings call transcript
2023 Q3
15 Aug 23
A
Earnings call transcript
2023 Q2
23 May 23
A
Earnings call transcript
2023 Q1
28 Feb 23
A
Earnings call transcript
2022 Q4
22 Nov 22
A
Earnings call transcript
2022 Q3
17 Aug 22
A
Earnings call transcript
2022 Q2
25 May 22
A
Earnings call transcript
2022 Q1
23 Feb 22
A
Earnings call transcript
2021 Q4
23 Nov 21
Latest ownership filings
SC 13G/A
VANGUARD GROUP INC
10 Apr 24
4
Philip Binns
27 Mar 24
144
Notice of proposed sale of securities
25 Mar 24
4
DOW R WILSON
19 Mar 24
4
GEORGE A SCANGOS
19 Mar 24
4
Sue H. Rataj
19 Mar 24
4
Daniel K Podolsky
19 Mar 24
4
HEIDI FIELDS
19 Mar 24
4
BOON HWEE KOH
19 Mar 24
4
Mikael Dolsten
19 Mar 24
Financial summary
Quarter (USD) | Oct 23 | Jul 23 | Apr 23 | Jan 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Oct 23 | Oct 22 | Oct 21 | Oct 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q4 2023
61.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 781 |
Opened positions | 141 |
Closed positions | 239 |
Increased positions | 258 |
Reduced positions | 256 |
13F shares | Current |
---|---|
Total value | 22.38 tn |
Total shares | 181.43 mm |
Total puts | 202.10 k |
Total calls | 194.20 k |
Total put/call ratio | 1.0 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 25.28 mm | $3.51 tn |
Massachusetts Financial Services | 13.25 mm | $1.84 tn |
STT State Street | 12.63 mm | $1.76 tn |
Wellington Management | 9.88 mm | $1.37 tn |
T. Rowe Price | 7.50 mm | $1.04 bn |
Pictet Asset Management Holding | 6.40 mm | $889.16 bn |
MS Morgan Stanley | 4.50 mm | $625.87 bn |
NTRS Northern Trust | 4.00 mm | $555.79 bn |
Cantillon Capital Management | 3.64 mm | $506.33 bn |
JPM JPMorgan Chase & Co. | 3.18 mm | $442.04 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | Philip Binns | Common Stock | Sell | Dispose S | No | No | 147.54 | 2,827 | 417.10 k | 9,997 |
15 Mar 24 | Rataj Sue H. | Common Stock | Grant | Acquire A | No | No | 147.48 | 1,678 | 247.47 k | 26,611 |
15 Mar 24 | Anand Mala | Common Stock | Grant | Acquire A | No | No | 147.48 | 1,678 | 247.47 k | 12,728 |
15 Mar 24 | Wilson Dow R | Common Stock | Grant | Acquire A | No | No | 147.48 | 1,678 | 247.47 k | 16,136.359 |
15 Mar 24 | Scangos George A | Common Stock | Grant | Acquire A | No | No | 147.48 | 1,678 | 247.47 k | 21,989.355 |
News
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
15 Apr 24
Barclays Maintains Underweight on Agilent Technologies, Raises Price Target to $135
10 Apr 24
(A) - Analyzing Agilent Technologies's Short Interest
10 Apr 24
Stifel Upgrades Agilent Technologies to Buy, Raises Price Target to $163
5 Apr 24
Evercore ISI Group Maintains In-Line on Agilent Technologies, Raises Price Target to $145
4 Apr 24
Press releases
Reitmans (Canada) Limited Reports Fiscal 2024 and Fourth Quarter Fiscal 2024 Financial Results
18 Apr 24
Agilent Receives Scientists' Choice Awards for Sustainability
16 Apr 24
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
15 Apr 24
Agilent Brings Great Science to Life at Analytica 2024
4 Apr 24
Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence
2 Apr 24